Regulations.gov document
Guidance on Antiviral Product Development — Conducting and Submitting Virology Studies to…
Other · FDA-2005-D-0282 · posted Oct 19, 2020
Key facts
| Document ID | FDA-2005-D-0282-0024 |
|---|---|
| Title | Guidance on Antiviral Product Development — Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HBV Resistance Data |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2005-D-0282 |
| Posted | Oct 19, 2020 |
| Comment period opens | Oct 19, 2020 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: